India Over The Counter Drugs Market by Product Type, Distribution Channel, End User 2023-2028

Report DescriptionAbout IMARC Group

International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all regions and industry verticals to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

India Over The Counter (OTC) Drugs Market Research Report 2023-2028:

According to the latest report by IMARC Group, titled " IndiaOverTheCounter(OTC)DrugsMarket:IndustryTrends,Share,Size,Growth,Opportunityand Forecast2023-2028

," the india over the counter (OTC) drugs market size reached US$ 7.6 Billion in 2022.

Over the counter (OTC) drugs, also known as non-prescription medicines, are consumed by individuals without any prescription from a healthcare professional. These medicines treat common self-treatable health conditions and symptoms such as headaches, constipation, toothache, cold and flu, heartburn, migraines, menstrual cramps, allergies, dental caries, and nausea.

They are safe for consumption, cost-effective, easily accessible, convenient, and time-saving. Over the years, there has been an escalating demand for OTC drugs in India due to the growing preference toward self-medication for minor health problems among individuals.

Request for a PDF sample of this report:

https://www.imarcgroup.com/india-over-the-counter-drugs-market/requestsample

India Over The Counter (OTC) Drugs Market Trends:

The market is primarily driven by the rising prevalence of chronic ailments among individuals across India. In addition, the growing inclination toward self-medication on account of high consulting fees charged by medical professionals is contributing to the market growth. Moreover, the escalating demand for OTC drugs to treat analgesics, gastrointestinal infections, coughs and colds, musculoskeletal pains, and fever represents another major growth-inducing factor. Besides this, the Government of India is taking several initiatives to make these drugs economical and accessible, spread awareness, and encourage the sales of OTC drugs, which is providing a positive thrust to the market growth.

Along with this, the increasing health awareness among consumers due to growing lifestyle-related diseases caused by sedentary lifestyles, poor eating habits, stress, and obesity is accelerating the product adoption rate. Apart from this, the increasing popularity of online pharmacies, the easy availability of OTC drugs, and continual product innovations are propelling market growth. Furthermore, the growing geriatric population, rising disposable incomes of consumers, and extensive research and development (R&D) activities conducted by key market players are also creating a favorable market outlook across the country.

Report Description Report Description and Highlights

Looking forward, IMARC Group expects the market value to reach US$ 19.4 Billion by 2028, exhibiting aCAGRof16.7%duringtheforecastperiod(2023-2028).

View Report TOC, Figures and Tables: https://www.imarcgroup.com/india-over-the-counter-drugs-market

Report Description Report Description and Highlights

Key Market Segmentation

The research report includes the following segments:

Breakup by Product Type:

• Cough, Cold and Flu Products

• Analgesics

• Dermatology Products

• Gastrointestinal Products

• Vitamins, Minerals and Supplements (VMS)

• Weight-loss/Dietary Products

• Ophthalmic Products

• Sleeping Aids

• Others

Breakup by Route of Administration:

• Oral

• Parenteral

• Topical

• Others

Report Description Report Description and Highlights

Breakup by Dosage Form:

• Tablets and Capsules

• Liquids

• Ointments

• Others

Breakup by Distribution Channel:

• Hospital Pharmacies

• Retail Pharmacies

• Online Pharmacies

• Others

Breakup by Region:

• North America

• Asia Pacific

• Europe

• Latin America

• Middle East and Africa

1. WhatwasthesizeoftheIndiaoverthecounter(OTC)drugsmarketin2022?

2. WhatistheexpectedgrowthrateoftheIndiaoverthecounter(OTC)drugsmarketduring20232028?

3. WhatarethekeyfactorsdrivingtheIndiaoverthecounter(OTC)drugsmarket?

4. WhathasbeentheimpactofCOVID-19ontheIndiaoverthecounter(OTC)drugsmarket?

5. WhatisthebreakupoftheIndiaoverthecounter(OTC)drugsmarketbasedontheproduct type?

6. WhatisthebreakupoftheIndiaoverthecounter(OTC)drugsmarketbasedonrouteof administration?

7. WhatisthebreakupoftheIndiaoverthecounter(OTC)drugsmarketbasedonthedosage form?

8. WhatisthebreakupoftheIndiaoverthecounter(OTC)drugsmarketbasedonthedistribution channel?

9. WhatarethekeyregionsintheIndiaoverthecounter(OTC)drugsmarket?

Clickheretovisitthecompletetableofcontentwithlistoffiguresandtables: https://www.imarcgroup.com/india-over-the-counter-drugs-market/toc

A partial List of our Clients

Partial List of Clients

We are the trusted business partners to the world's leading corporates, governments, and institutions

A partial List of our Clients

Partial List of Clients

We are the trusted business partners to the world's leading corporates, governments, and institutions

Report Description Report Description and Highlights

© 2022 IMARC All Rights Reserved

This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC).

Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication.

IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.